Plenary Session 1102

Novel Genetic Therapies for Movement Disorders

Friday, February 13, 2026
10:15 - 12:00 | Houston Ballroom

In this session, the faculty will present and discuss the development of novel genetic therapies for specific movement disorders including Parkinson's disease, Huntington's disease, and rare metabolic disorders.

Chairs:

Hyder Jinnah, USA

Presenters:

Novel Genetic Therapies for Parkinson's Disease
S. Pablo Sardi, USA

Novel Genetic Therapies for Huntington's Disease

Novel Genetic Therapies for Rare Metabolic Disorders
Jennifer Friedman, USA

CSPC Liaisons:

Hyder Jinnah, USA
Malco Rossi, Argentina

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Evaluate recent preclinical studies and clinical trial data for novel genetic therapies for Parkinson's disease.
2. Evaluate recent preclinical studies and clinical trial data for novel genetic therapies for Huntington's disease.
3. Evaluate recent preclinical studies and clinical trial data for novel genetic therapies for rare metabolic disorders.

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level

Beginner / Foundational
Experienced
Expert